Third party funding

Third Party Funding

  • DFG SFB_TR36
  • German Center for Infection Research (DZIF)
  • Helmholtz Alliances “Immunotherapy of Cancer” and „Synthetic Biology“
  • Helmholtz-Alberta Initiative on Infection Research
  • Helmholtz Validation Fond
  • Innovation Funds, Federal Ministry for Economic Affairs Germany

Industry research collaborations:

  • Roche Inc., Paolo Alto, CA, USA
  • Janssen Pharmaceutica, Beerse, Belgium
  • GILEAD Sciences, Foster City, USA
  • Leukocare, Munich
  • Rheinbiotech – Dynavax Europe, Düsseldorf, Germany